Mitochondria-Targeting and Oxygen Self-Supplying Eccentric Hollow Nanoplatform for Enhanced Breast Cancer Photodynamic Therapy

Figure 5

(a) Hemolytic activity of different concentrations of EHMONs-Ce6-CTPP; (b) cell survival of 4T1 cells incubated with different concentrations of EHMONs-Ce6-CTPP for 24 h and 48 h, respectively; (c) cell survival of 4T1 cells underwent treatment of Ce6 + laser, EHMONs-Ce6-CTPP@PFC, EHMONs-Ce6-CTPP + laser, and EHMONs-Ce6-CTPP@PFC + laser groups.

(a)

(b)

(c)